These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 646319)

  • 21. [Influence of anti-H2-receptors on the surgery of peptic ulcer].
    Cavallesco NG; Morsiani E; Lupi L; Dalla Valle GB; Fogli L; Belcastro S; Pampolini M; Pollice S; Santini A
    Minerva Chir; 1987 Oct; 42(19):1495-7. PubMed ID: 2891086
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ulcer recurrence after selective proximal vagotomy (review of the literature)].
    Cherniavskiĭ AA; Zubeev PS
    Khirurgiia (Mosk); 1984 Sep; (9):143-5. PubMed ID: 6392705
    [No Abstract]   [Full Text] [Related]  

  • 23. [The results of dynamic observation over patients with stomach and duodenum ulcer diseases after Helicobacter pylori eradication].
    Kas'ianenko VI
    Eksp Klin Gastroenterol; 2007; (4):19-24. PubMed ID: 18409486
    [No Abstract]   [Full Text] [Related]  

  • 24. [Early results following 2/3-resection of the stomach in elective surgery of stomach ulcer and duodenal ulcer. A comparison of performances by Billroth I and Billroth II methods].
    Weber PM; Schramm H
    Z Arztl Fortbild (Jena); 1983; 77(17):725-7. PubMed ID: 6649685
    [No Abstract]   [Full Text] [Related]  

  • 25. [Peptic ulcer: changes in the surgical approach after the introduction of H2-antagonists in clinical practice].
    Rimassa PL; Marino G; Quartapelle V; D'Asta F; Maggiolo G; Manno A; Piffero D; Schiappacasse E
    Minerva Chir; 1987 Oct; 42(19):1499-502. PubMed ID: 2891087
    [No Abstract]   [Full Text] [Related]  

  • 26. [Surgical treatment of gastroduodenal ulcer disease. Our experience after the advent of H2-antagonist drugs].
    Carrella G; Salomoni C; De Anna D; Pozza E; Sortini A; Guerrera C; Pansini GC; Marcello D; Vettorello GF
    Minerva Chir; 1987 Oct; 42(19):1483-5. PubMed ID: 2891084
    [No Abstract]   [Full Text] [Related]  

  • 27. On the cause of gastric and duodenal ulcers.
    Dragstedt LR
    J R Coll Surg Edinb; 1971 Sep; 16(5):251-63. PubMed ID: 5115272
    [No Abstract]   [Full Text] [Related]  

  • 28. [Non-alternative elements in the pathogenesis of peptic ulcer and their modulation with sodium nucleinate].
    Perederiĭ VG; Zemskov AM
    Ter Arkh; 1983; 55(2):29-32. PubMed ID: 6189204
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the choice of surgical interventions in uncomplicated gastric and duodenal ulcers].
    Zenker R; Reichel K; Lorenz W; Haendle H; Feifel G
    Chirurg; 1968 Nov; 39(11):488-90. PubMed ID: 5704015
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of duodenal ulcer, complicated by gastric ulcer, with vagotomy].
    Kurygin AA; Dozortsev VF
    Khirurgiia (Mosk); 1973 Aug; 49(8):115-8. PubMed ID: 4760192
    [No Abstract]   [Full Text] [Related]  

  • 31. [Results of clinical treatment of gastric and duodenal ulcers].
    Vasconcellos D
    Rev Esp Enferm Apar Dig; 1970 Mar; 30(5):609-20. PubMed ID: 5435381
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy of the gastric and duodenal ulcer. Clinico-statistical study on the use of a new drug: sulfoglycopeptide].
    Fazzini G; Giampaglia G; Scarpulla P
    Minerva Chir; 1974 Sep; 29(17):933-5. PubMed ID: 4608974
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of peptic ulcer disease and nonulcer dyspepsia.
    Meurer LN
    J Fam Pract; 2001 Jul; 50(7):614-9. PubMed ID: 11485712
    [No Abstract]   [Full Text] [Related]  

  • 34. [The role of surgery in the comparison of peptic ulcer before and after the advent of H2 receptor blockers in the light of our experience].
    Pinto E; Verre L; De Stefano A; Trombì G
    Minerva Chir; 1987 Sep; 42(18):1375-82. PubMed ID: 2892149
    [No Abstract]   [Full Text] [Related]  

  • 35. [Indications and results of the endoscopic treatment of hemorrhaging ulcers].
    Barthet M; Sahel J
    Ann Chir; 1997; 51(1):10-4; discussion 15-20. PubMed ID: 9309883
    [No Abstract]   [Full Text] [Related]  

  • 36. [Gastric ulcer and duodenal ulcer. Therapeutic problems and trends].
    Montorsi W
    Minerva Med; 1971 Mar; 62(23):1238-9. PubMed ID: 5552929
    [No Abstract]   [Full Text] [Related]  

  • 37. [Is gastric and duodenal ulcer drug-treatable or surgical disease?].
    Fedele E
    Chir Ital; 1997; 49(1-2):5-8. PubMed ID: 12743869
    [No Abstract]   [Full Text] [Related]  

  • 38. [Peptic ulcers after gastrojejunoduodenoplasty performed for stomach and duodenal ulcers].
    Seniutovich VF; Sikor ZG
    Khirurgiia (Mosk); 1969 Dec; 45(12):65-8. PubMed ID: 5383256
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical importance of antagonists of histamine H2 receptors in gastroenterology].
    Carella G
    Clin Ter; 1984 Mar; 108(6):525-9. PubMed ID: 6144411
    [No Abstract]   [Full Text] [Related]  

  • 40. [Secondary stomach ulcers after organ-sparing operations in duodenal ulcer].
    Borisov VF; Vasilenko LI; Kunitskiĭ IuL
    Vestn Khir Im I I Grek; 1988 Jun; 140(6):25-8. PubMed ID: 3222857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.